IDXX IDEXX Laboratories, Inc.

NASDAQ
$698.47

IDEXX Laboratories, Inc. (IDXX) Insider Activity

What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.

Insider signal Bearish Selling ran elevated versus IDXX's own trailing one-year pace, with 0% of sale value under a prearranged plan.
Cluster activity 0 buyers in the last 30 days 0 buyers in the last 90 days 5 sellers in the last 90 days
Insiders buying
0
0 transactions
Insiders selling
5
22 transactions
Purchases
$0
0 shares
Sales
$28.6M
41,428 shares
Net activity
-$28.6M
purchases less sales

How much of that selling was preplanned? 0% planned / 100% discretionary

10b5-1 plan sales $0 0 transactions · 0 shares
Discretionary sales $28.6M 22 transactions · 41,428 shares

Largest single sale: $4.4M.

Where they traded

Buy Sell Dot area is proportional to transaction value.

No open-market insider purchase on record.

Recent open-market activity

Date Insider Role Action Shares Price Value Held after
MAZELSKY JONATHAN JAY 13 fills Executive Chair of the Board Sell 25,140 $703.19 $17.7M 106,998 −19% of holding
Underberg Sharon E. 3 fills EVP, GC & Corporate Secretary Sell 8,906 $688.59 $6.1M 9,727 −47.8% of holding
Lane Michael 3 fills Executive Vice President Sell 3,979 $688.64 $2.7M 7,812 −33.7% of holding
JUNIUS DANIEL M 2 fills Director Sell 1,200 $704.07 $844.9K 2,861 −29.5% of holding
Kingsley Lawrence D Director Sell 2,203 $532.08 $1.2M 9,568 −18.7% of holding

Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.